Institutional Ownership Cytokinetics Inc (CYTK)
This table provides information about the institutional ownership of Cytokinetics Inc (CYTK). We have compiled data on the 406 institutions that hold shares in the stock, with a total of 127 Million shares, which have been reported (via 13F filing form) to have a value of $4.69 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
14,672,779
shares
|
$553 Million
0.02% of portfolio
|
Q2 2024
Added 18.19%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
11,849,547
shares
|
$447 Million
0.01% of portfolio
|
Q1 2025
Reduced 0.56%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 14, 2025 Q1 2025 |
9,955,251
shares
|
$375 Million
0.26% of portfolio
|
Q1 2025
Reduced 7.41%
|
|
Wellington Management Group LLP
Boston, MA |
May 13, 2025 Q1 2025 |
7,988,740
shares
|
$301 Million
0.06% of portfolio
|
Q1 2025
New holding
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
6,085,001
shares
|
$229 Million
0.01% of portfolio
|
Q1 2025
Reduced 1.34%
|
|
Deep Track Capital, LP
Greenwich, CT |
May 15, 2025 Q1 2025 |
3,073,853
shares
|
$116 Million
4.32% of portfolio
|
Q1 2025
Added 22.95%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
2,937,484
shares
|
$111 Million
0.01% of portfolio
|
Q1 2025
Added 3.38%
|
|
Rtw Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
2,721,158
shares
|
$103 Million
1.79% of portfolio
|
Q2 2024
Added 7.77%
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
2,702,874
shares
|
$102 Million
0.01% of portfolio
|
Q1 2025
Added 1133.51%
|
|
Vestal Point Capital, LP
New York, NY |
May 15, 2025 Q1 2025 |
2,590,531
shares
|
$97.7 Million
7.43% of portfolio
|
Q1 2025
Added 10.24%
|
|
Polar Capital Holdings PLC
London, X0 |
May 15, 2025 Q1 2025 |
2,455,737
shares
|
$92.6 Million
0.66% of portfolio
|
Q1 2025
Added 11.79%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
2,252,206
shares
|
$84.9 Million
0.09% of portfolio
|
Q2 2023
Reduced 0.8%
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
2,134,219
shares
|
$80.5 Million
0.02% of portfolio
|
Q1 2025
Added 77.56%
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
2,028,792
shares
|
$76.5 Million
0.11% of portfolio
|
Q1 2025
Reduced 5.78%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
1,993,896
shares
|
$75.2 Million
0.01% of portfolio
|
Q1 2025
Reduced 24.04%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 05, 2025 Q1 2025 |
1,956,327
shares
|
$73.8 Million
0.09% of portfolio
|
Q1 2025
Added 2.32%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Jul 21, 2025 Q1 2025 |
1,722,984
shares
|
$65 Million
0.17% of portfolio
|
Q1 2025
Added 914.04%
|
|
Alliancebernstein L.P.
New York, NY |
May 15, 2025 Q1 2025 |
1,523,440
shares
|
$57.4 Million
0.02% of portfolio
|
Q1 2025
Reduced 4.51%
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
1,509,205
shares
|
$56.9 Million
1.89% of portfolio
|
Q1 2025
Reduced 4.72%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
1,447,316
shares
|
$54.6 Million
0.01% of portfolio
|
Q1 2025
Reduced 1.64%
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
1,362,958
shares
|
$51.4 Million
0.01% of portfolio
|
Q1 2025
Reduced 1.42%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
1,325,408
shares
|
$50 Million
0.0% of portfolio
|
Q1 2025
Reduced 18.1%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
1,312,857
shares
|
$49.5 Million
0.01% of portfolio
|
Q1 2025
Reduced 1.67%
|
|
Westfield Capital Management CO LP
Boston, MA |
May 09, 2025 Q1 2025 |
1,310,336
shares
|
$49.4 Million
0.27% of portfolio
|
Q1 2025
Added 2.37%
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
May 15, 2025 Q1 2025 |
1,256,580
shares
|
$47.4 Million
0.96% of portfolio
|
Q1 2025
Added 27.02%
|